Stocks and Investing Stocks and Investing
Fri, March 26, 2021
Thu, March 25, 2021

Josh Schimmer Initiated (VIRX) at Buy and Held Target at $45 on, Mar 25th, 2021


Published on 2024-10-27 16:02:34 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Evercore ISI Group, Initiated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $45 on, Mar 25th, 2021.

Josh, nor any peers, have made any analyst calls on VIRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources